JPH0645530B2 - External skin preparation - Google Patents
External skin preparationInfo
- Publication number
- JPH0645530B2 JPH0645530B2 JP60056488A JP5648885A JPH0645530B2 JP H0645530 B2 JPH0645530 B2 JP H0645530B2 JP 60056488 A JP60056488 A JP 60056488A JP 5648885 A JP5648885 A JP 5648885A JP H0645530 B2 JPH0645530 B2 JP H0645530B2
- Authority
- JP
- Japan
- Prior art keywords
- dimethylethyl
- skin
- external preparation
- present
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims description 20
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 150000005846 sugar alcohols Polymers 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- HIPQTCQUXOFTFI-UHFFFAOYSA-N 2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)C(=O)C1=CC=CC=C1 HIPQTCQUXOFTFI-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 230000006750 UV protection Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- -1 polyglycerin Chemical compound 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- XCQFTFZCTGZCNP-UHFFFAOYSA-N 2-(2-ethylhexanoyloxy)ethyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCCOC(=O)C(CC)CCCC XCQFTFZCTGZCNP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- ONTNTIWDWMGWEO-UHFFFAOYSA-N C(CCCCCCCCCCCCCCCCC)(=O)OCC(O)CO.C(CCCCCCCCC)(=O)O.C(CCCCCCCCC)(=O)O Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)OCC(O)CO.C(CCCCCCCCC)(=O)O.C(CCCCCCCCC)(=O)O ONTNTIWDWMGWEO-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000005417 aminobenzoic acid derivatives Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は4−(1,1−ジメチルエチル)−4′−メト
キシジベンゾイルメタンとともに、多価アルコールと脂
肪酸との液状多価エステルを配合することにより優れた
紫外線防御効果と、すぐれた品質をもつ皮膚外用剤に関
するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention blends liquid polyhydric ester of polyhydric alcohol and fatty acid together with 4- (1,1-dimethylethyl) -4′-methoxydibenzoylmethane. The present invention relates to a skin external preparation having excellent UV protection effect and excellent quality.
[従来の技術] 太陽光線は日焼けをおこすばかりか、その日焼けのため
に皮膚の老化を促進することが知られている。[Prior Art] It is known that sun rays not only cause sunburn but also promote skin aging due to the sunburn.
太陽光線を防ぐように配慮された皮膚外用剤はすくなく
ないが、そのいずれもが粉末を配合して主として反射、
散乱によって対処したもの、あるいはUV−Bとよばれ
る比較的波長の短かい紫外線のみを吸収するサリチル酸
誘導体、アミノ安息香酸誘導体のような物質を配合した
ものであった。There are not a few skin external preparations designed to prevent the sun's rays, but all of them are powdered and mainly reflected,
It was dealt with by scattering, or was compounded with substances called UV-B such as salicylic acid derivatives and aminobenzoic acid derivatives that absorb only ultraviolet rays having a relatively short wavelength.
[発明が解決しようとする問題点] 4−(1,1−ジメチルエチル)−4′−メトキシジベ
ンゾイルメタンは太陽光線、特に皮膚に対して有害なU
V−Aとよばれる比較的長波長の紫外線を吸収する物質
として近年脚光をあびているが、皮膚外用剤基剤との相
溶性が悪く、溶解状態で皮膚外用剤に配合しても比較的
短時間のうちに結晶として析出してしまうことが多い。[Problems to be Solved by the Invention] 4- (1,1-Dimethylethyl) -4′-methoxydibenzoylmethane is a harmful U to sun rays, especially to the skin.
Recently, it has been spotlighted as a substance called VA that absorbs ultraviolet rays having a relatively long wavelength, but its compatibility with the skin external preparation base is poor, and it is relatively short even if it is mixed with the skin external preparation in a dissolved state. It often precipitates as crystals over time.
結晶として析出した場合は皮膚外用剤の品質を著しく損
ねることは言うまでもなく、本来の目的の紫外線吸収能
さえも発揮できない状態となってしまう。Needless to say, when the crystals are deposited as crystals, the quality of the external preparation for skin is significantly impaired, and even the UV absorption ability for the original purpose cannot be exhibited.
[問題点を解決するための手段] 本発明者は係る事情に鑑み鋭意研究の結果、4−(1,
1−ジメチルエチル)−4′−メトキシジベンゾイルメ
タンとともに、多価アルコールと脂肪酸との液状多価エ
ステルを配合すれば、紫外線吸収効果に優れることはも
ちろん、長期間安定性に優れ品質劣化をおこすことのす
くない皮膚外用剤を得られることを見出し本発明を完成
するに至った。[Means for Solving Problems] As a result of earnest research in view of such circumstances, the present inventor has found that 4- (1,
By blending 1-dimethylethyl) -4'-methoxydibenzoylmethane with a liquid polyhydric ester of a polyhydric alcohol and a fatty acid, not only the UV absorption effect is excellent, but also the long-term stability is excellent and quality deterioration occurs. The inventors have found that a topical skin external preparation can be obtained, and completed the present invention.
すなわち本発明は優れた紫外線吸収効果、優れた品質を
もつ皮膚外用剤を提供するものである。That is, the present invention provides a skin external preparation having an excellent ultraviolet absorbing effect and an excellent quality.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be described in detail.
本発明で用いられる4−(1,1−ジメチルエチル)−
4′−メトキシジベンゾイルメタンは、特開昭55−6
6535に示される方法で製造され、ジボダン株式会社
より「パルソール1789」の商品名で供給されてい
る。4- (1,1-dimethylethyl) -used in the present invention
4'-methoxydibenzoylmethane is disclosed in JP-A-55-6.
It is manufactured by the method shown in 6535, and is supplied by Givaudan Co., Ltd. under the trade name of "Pulsol 1789".
皮膚外用剤に配合する量としては期待する紫外線吸収効
果に応じて任意であるが、極端に配合量が多い場合に
は、皮膚外用剤基剤の分量がすくなくなり、好ましくな
い。好ましくは0.01〜10%である。0.01%以
下では紫外線吸収効果が少なく本来の目的を発揮でき
ず、10%を越える場合には皮膚外用剤基剤の分量が減
り皮膚外用剤そのものとしての品質が損なわれる。The amount to be added to the external preparation for skin is optional depending on the expected UV absorption effect, but if the amount is extremely large, the amount of the base for external preparation for skin becomes too small, which is not preferable. It is preferably 0.01 to 10%. If it is less than 0.01%, the ultraviolet absorbing effect is small and the intended purpose cannot be achieved. If it exceeds 10%, the amount of the base agent for external preparation for skin is reduced and the quality of the external preparation for skin itself is impaired.
本発明の効果を発揮する目的で配合される多価アルコー
ルと脂肪酸との液状多価エステルを構成する多価アルコ
ールとしては、たとえばエチレングリコール、プロピレ
ングリコール、ネオペンチルグリコール、グリセリン、
ジグリセリン、ポリグリセリン、トリメチロールプロパ
ン、ペンタエリスリトール、ソルビタンなど、また脂肪
酸としては炭素数8ないし22の直鎖、分岐、不飽和脂
肪酸、たとえばn−デカン酸、2−エチルヘキサン酸、
イソステアリン酸、オレイン酸、リノール酸などが有名
である。Examples of the polyhydric alcohol constituting the liquid polyhydric ester of a polyhydric alcohol and a fatty acid to be blended for the purpose of exerting the effect of the present invention include, for example, ethylene glycol, propylene glycol, neopentyl glycol, glycerin,
Diglycerin, polyglycerin, trimethylolpropane, pentaerythritol, sorbitan, and the like, and fatty acids having 8 to 22 carbon atoms, such as straight chain, branched, and unsaturated fatty acids, for example, n-decanoic acid, 2-ethylhexanoic acid,
Isostearic acid, oleic acid, linoleic acid, etc. are famous.
多価アルコールと脂肪酸との液状多価エステルとしては
グリセリルトリ(2−エチルヘキサノエート)、グリセ
リルトリイソステアレート、グリセリルジイソステアレ
ート、グリセリルジ(2−エチルヘキサノエート)、ペ
ンタエリスリトール−テトラ(2−エチルヘキサノエー
ト)、プロピレングリコール−ジオレート、エチレング
リコールジ(2−エチルヘキサノエート)、ネオペンチ
ルグリコールジ(n−デカノエート)、ジグリセリンジ
イソステアレート、ソルビタンセスキオレートなどが入
手しやすい。Examples of the liquid polyhydric ester of polyhydric alcohol and fatty acid include glyceryl tri (2-ethylhexanoate), glyceryl triisostearate, glyceryl diisostearate, glyceryl di (2-ethylhexanoate), pentaerythritol- Tetra (2-ethylhexanoate), propylene glycol-diolate, ethylene glycol di (2-ethylhexanoate), neopentyl glycol di (n-decanoate), diglycerin diisostearate, sorbitan sesquioleate, etc. are available. It's easy to do.
これらのエステルを一種または二種以上配合するが、本
発明の効果を発揮する目的で配合される量としては4−
(1,1−ジメチルエチル)−4′−メトキシジベンゾ
イルメタンの量に対して1/2以上が必要であり、過剰
に配合しても本発明の効果を阻害するものではない。These esters are blended in one kind or two or more kinds, but as an amount to be mixed for the purpose of exerting the effect of the present invention, 4-
The amount of (1,1-dimethylethyl) -4'-methoxydibenzoylmethane is required to be 1/2 or more, and even if it is added in excess, the effect of the present invention is not impaired.
本発明において4−(1,1−ジメチルエチル)−4′
−メトキシジベンゾイルメタンと多価アルコールと脂肪
酸との液状多価エステルを配合される皮膚外用剤基剤と
しては通常の皮膚外用剤基剤ならばいずれのものも利用
できる。In the present invention, 4- (1,1-dimethylethyl) -4 '
Any conventional skin external preparation base can be used as the skin external preparation base in which the liquid polyvalent ester of -methoxydibenzoylmethane, polyhydric alcohol and fatty acid is blended.
すなわち、液状、ゲル状、ペースト状、クリーム状など
のもので、皮膚外用剤を修飾する成分として保湿剤、油
分、界面活性剤、増粘剤、金属封鎖剤、その他の紫外線
吸収剤、薬剤、色素、香料などが併用できることは言う
までもない。That is, liquids, gels, pastes, creams and the like, as a component for modifying the skin external preparation, moisturizers, oils, surfactants, thickeners, sequestering agents, other ultraviolet absorbers, drugs, It goes without saying that dyes and fragrances can be used in combination.
[実施例] <実施例1>サンスクリーンオイル 4−(1,1−ジメチルエチル) 2wt% −4′−メトキシジベンゾイル メタン グリセリルトリ(2−エチルヘキサ 10 ノエート) (商品名:RA−G−308) 流動パラフィン 88 [発明の効果] 実施例1は本発明にしたがって4−(1,1−ジメチル
エチル)−4′−メトキシジベンゾイルメタンと、液状
の多価アルコール脂肪酸エステルを配合した皮膚外用剤
である。[Examples] <Example 1> Sunscreen oil 4- (1,1-dimethylethyl) 2 wt% -4'-methoxydibenzoyl methane glyceryl tri (2-ethylhexa 10 noate) (trade name: RA-G-308) ) Liquid paraffin 88 [Effect of the invention] Example 1 is an external preparation for skin containing 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane and a liquid polyhydric alcohol fatty acid ester in accordance with the present invention. Is.
一方、4−(1,1−ジメチルエチル)−4′−メトキ
シジベンゾイルメタンを配合しない場合、および液状の
多価アルコール脂肪酸エステルを配合しない場合を対照
例として下記に示す。On the other hand, the case where 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane is not mixed and the case where liquid polyhydric alcohol fatty acid ester is not mixed are shown below as control examples.
<対照例1> 4−(1,1−ジメチルエチル) 2wt% −4′−メトキシジベンゾイル メタン スクワワン 10 流動パラフィン 88 <対照例2> グリセリルトリ(2−エチルヘキサ 10wt% ノエート) (商品名:RA−G−308) 流動パラフィン 90 表1に保存安定性および紫外線防御効果を示す。<Comparative Example 1> 4- (1,1-dimethylethyl) 2 wt% -4'-methoxydibenzoyl methane squawan 10 liquid paraffin 88 <Comparative example 2> Glyceryl tri (2-ethylhexa 10 wt% noate) (trade name: RA -G-308) Liquid paraffin 90 Table 1 shows the storage stability and UV protection effect.
実施例1および対照例1、2の皮膚外用剤はいずれもサ
ンスクリーンオイルとして使用されるものである。The external preparations for skin of Example 1 and Comparative Examples 1 and 2 are all used as sunscreen oils.
対照例1は製造直後は均一な液状であるものの4−
(1,1−ジメチルエチル)−4′−メトキシジベンゾ
イルメタンが徐々に析出し皮膚外用剤としての品質が劣
化し紫外線防御効果さえも減少してくる。Although Comparative Example 1 was a uniform liquid immediately after the production, 4-
(1,1-Dimethylethyl) -4'-methoxydibenzoylmethane is gradually deposited, and the quality of the external skin preparation is deteriorated, and even the ultraviolet protection effect is reduced.
対照例2は結晶が析出することはないが紫外線防御効果
については当然期待できない。In Comparative Example 2, crystals are not precipitated, but the UV protection effect cannot be expected.
これに対し実施例1は、製造直後はもちろん長期間保存
したあとでも結晶が析出することがなく、紫外線防御効
果に優れ、品質が安定している。On the other hand, in Example 1, the crystals are not precipitated immediately after the production and also after the storage for a long period of time, the ultraviolet protection effect is excellent, and the quality is stable.
これは本発明に係る技術を応用した結果である。This is a result of applying the technique according to the present invention.
次に本発明をより多くの実施例で詳述するが本発明はこ
れにより限定されるものではない。 The present invention will now be described in more detail with reference to more examples, but the present invention is not limited thereto.
実施例2 A.セタノール 3wt% ステアリン酸 3 ワセリン 3 ネオペンチルグリコール 3 ジ(n−デカノエート) グリセリルモノステアレート 2 ソルビタンセスキオレート 2 スクワラン 5 4−(1,1−ジメチルエチル) 2 −4′−メトキシジベンゾイル メタン 香料 適量 B.プロピレングリコール 3 水酸化カリウム 0.2 精製水 全体を100とする量 Aの油相部分とBの水相部分をそれぞれ70℃で加熱溶
解し、AをBに加え乳化する。そののち冷却処理をして
クリームを得る。Example 2 A. Cetanol 3 wt% Stearic acid 3 Vaseline 3 Neopentyl glycol 3 Di (n-decanoate) Glyceryl monostearate 2 Sorbitan sesquioleate 2 Squalane 5 4- (1,1-Dimethylethyl) 2-4'-methoxydibenzoyl methane fragrance Suitable amount B. Propylene glycol 3 Potassium hydroxide 0.2 Purified water based on the total amount of 100 An oil phase portion of A and an aqueous phase portion of B are dissolved by heating at 70 ° C., and A is added to B to emulsify. Then, it is cooled to obtain a cream.
実施例3 4−(1,1−ジメチルエチル) 5wt% −4′−メトキシジベンゾイル メタン 固形パラフィン 20 ワセリン 20 ヒマシ油 40 グリセリルトリイソステアレート 5 ジグリセリンジイソステアレート 3 調合色剤(赤色系) 7 香料 適量 上記の各原料を80℃で加熱溶解し、そののち所定の容
器に流し込みリップスティックを得る。Example 3 4- (1,1-dimethylethyl) 5 wt% -4'-methoxydibenzoyl methane Solid paraffin 20 Vaseline 20 Castor oil 40 Glyceryl triisostearate 5 Diglycerin diisostearate 3 Formulation colorant (red color) 7) Perfume proper amount Each of the above raw materials is heated and melted at 80 ° C., and then poured into a predetermined container to obtain a lipstick.
実施例4 A.ステアリルアルコール 2wt% ステアリン酸 2 精製ラノリン 2 ペンタエリスリトール−テトラ 5 (2−エチルヘキサノエート) グリセリルモノリノレート 1 グリセリルモノステアレート 2 4−(1,1−ジメチルエチル) 2 −4′−メトキシジベンゾイル メタン 防腐剤 適量 香料 適量 B.グリセリン 5 水酸化カリウム 0.2 精製水 全体を100とする量 C.調合粉末 10 Aの油相原料、Bの水相原料をそれぞれ70℃で加熱溶
解したのちAをBに加えて乳化する。そのものにCの粉
末部を分散処理しついで冷却処理して、クリーム状ファ
ンデーションを得る。Example 4 A. Stearyl alcohol 2 wt% Stearic acid 2 Purified lanolin 2 Pentaerythritol-tetra 5 (2-ethylhexanoate) Glyceryl monolinoleate 1 Glyceryl monostearate 2 4- (1,1-Dimethylethyl) 2-4'-methoxydi Benzoyl methane Preservative Amount Perfume Amount B. Glycerin 5 Potassium hydroxide 0.2 Purified water 100 as a whole C.I. Formulated powder 10 A oil phase raw material and B aqueous phase raw material are heated and melted at 70 ° C., respectively, and then A is added to B and emulsified. A powdery portion of C is dispersed therein and then cooled to obtain a cream foundation.
実施例5 エチレングリコールジ 50wt% (2−エチルヘキサノエート) グリセリルトリ(2−エチル 10 ヘキサノエート) トリメチロールプロパントリ 15 イソステアレート 流動パラフィン 10 4−(1,1−ジメチルエチル)10 −4′−メトキシジベンゾイル メタン 色素 適量 香料 適量 上記の各成分を50℃で加熱溶解したのち撹拌冷却しボ
ディ用オイルを得る。Example 5 Ethylene glycol di 50 wt% (2-ethylhexanoate) Glyceryl tri (2-ethyl 10 hexanoate) Trimethylolpropane tri 15 isostearate Liquid paraffin 10 4- (1,1-Dimethylethyl) 10 -4 ' -Methoxydibenzoyl methane dye Appropriate amount Perfume Appropriate amount Each of the above components is dissolved by heating at 50 ° C and then stirred and cooled to obtain a body oil.
実施例6 固形パラフィン 10wt% 流動パラフィン 全体を100とする量 ワセリン 20 グリセリルモノステアレート 5 ジグリセリン 0.05 ジイソステアレート 4−(1,1−ジメチルエチル) 0.1 −4′−メトキシジベンゾイル メタン 香料 適量 上記の各成分を50℃で加熱溶解したのち撹拌冷却しボ
ディ用ゲルを得る。Example 6 Solid paraffin 10 wt% Liquid paraffin Total amount of 100 Vaseline 20 Glyceryl monostearate 5 Diglycerin 0.05 Diisostearate 4- (1,1-Dimethylethyl) 0.1 -4'-Methoxydi Benzoyl methane fragrance Appropriate amount Each of the above components is dissolved by heating at 50 ° C., followed by stirring and cooling to obtain a body gel.
実施例2〜6の皮膚外用剤は紫外線吸収効果に優れ、ま
た製造後3ヶ月経ても結晶の析出による品質の劣化は皆
無であった。The external preparations for skin of Examples 2 to 6 were excellent in the effect of absorbing ultraviolet rays, and there was no deterioration in quality due to precipitation of crystals even after 3 months from the production.
これは本発明に係る技術を応用した結果である。This is a result of applying the technique according to the present invention.
Claims (1)
メトキシジベンゾイルメタンとともに、多価アルコール
と脂肪酸との液状多価エステルを配合したことを特徴と
する皮膚外用剤。1. 4- (1,1-Dimethylethyl) -4'-
A skin external preparation characterized in that a liquid polyvalent ester of a polyhydric alcohol and a fatty acid is blended together with methoxydibenzoylmethane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60056488A JPH0645530B2 (en) | 1985-03-20 | 1985-03-20 | External skin preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60056488A JPH0645530B2 (en) | 1985-03-20 | 1985-03-20 | External skin preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61215315A JPS61215315A (en) | 1986-09-25 |
| JPH0645530B2 true JPH0645530B2 (en) | 1994-06-15 |
Family
ID=13028480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60056488A Expired - Lifetime JPH0645530B2 (en) | 1985-03-20 | 1985-03-20 | External skin preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0645530B2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8925473D0 (en) * | 1989-11-10 | 1989-12-28 | Unilever Plc | Sunscreen compositions |
| JP3537622B2 (en) * | 1996-02-26 | 2004-06-14 | 株式会社資生堂 | UV absorbing composition |
| FR2768730B1 (en) * | 1997-09-25 | 1999-12-31 | Jean Noel Thorel | PROCESS FOR THE PHOTOSTABILIZATION OF 4- (TER.BUTYL) 4'-METHOXY DIBENZOYLMETHANE, FILTERING COMPOSITIONS THUS OBTAINED AND THEIR USES |
| TWI414320B (en) * | 2004-05-13 | 2013-11-11 | 久光製藥股份有限公司 | Transdermal preparation containing non-steroidal anti-inflammatory analgesic |
| JP2007320851A (en) * | 2004-09-10 | 2007-12-13 | Kose Corp | Skin care preparation for external use |
| CN103058845A (en) * | 2013-01-08 | 2013-04-24 | 河南师范大学 | Dibenzoylmethane preparation method |
| JP2024158041A (en) * | 2023-04-27 | 2024-11-08 | ジェイオーコスメティックス株式会社 | Cosmetics, their production method, and ultraviolet protection agent composition |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056489A (en) * | 1983-09-09 | 1985-04-02 | Hitachi Zosen Corp | High frequency resistance welding method |
-
1985
- 1985-03-20 JP JP60056488A patent/JPH0645530B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61215315A (en) | 1986-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2238775T3 (en) | FLUIDIFIED POLYMERIC SUSPENSIONS OF CATIONIC POLYSACARIDS IN EMOLIENTS AND THEIR USE IN THE PREPARATION OF COMPOSITIONS FOR PERSONAL CARE. | |
| JP3661706B2 (en) | Topical skin preparation | |
| US6630151B1 (en) | Method of increasing viscosity of oil-based compositions and compositions resulting therefrom | |
| JP3894064B2 (en) | Oil-based thickening gel composition, emulsified composition using the composition, and preparation method thereof | |
| JP2506384B2 (en) | Topical | |
| JP5540243B2 (en) | Sunscreen cosmetics | |
| JPH10226615A (en) | Composition containing aspartic acid-phenylalanine cyclic dipeptide derivative | |
| JPH0645530B2 (en) | External skin preparation | |
| KR20010075028A (en) | Oil-in-water emulsion composition | |
| JPH0751491B2 (en) | Emulsified cosmetics containing crude drugs | |
| JP2005514340A6 (en) | Use of alkyl polyglycosides as emulsifiers for the preparation of oil-in-water emulsions containing inorganic fillers or pigments, and oil-in-water emulsions containing such alkyl polyglycosides | |
| JP2879985B2 (en) | Emulsion type cosmetic | |
| KR950007906B1 (en) | Long wave uv ray absorber and its cosmetics | |
| JPH0645531B2 (en) | External skin preparation | |
| JPH0532531A (en) | Cosmetic | |
| JPH0525853B2 (en) | ||
| JP2854767B2 (en) | Thickening gelling agent | |
| WO2001062224A1 (en) | Stabilized emulsion compositions | |
| JPS61215311A (en) | External agent for skin | |
| JPH0543682B2 (en) | ||
| JP3057207B2 (en) | External preparation for skin | |
| JP2002332207A (en) | Solid transparent cosmetic | |
| JPH01146815A (en) | External preparation for skin | |
| JPS61215317A (en) | External agent for skin | |
| JP2533775B2 (en) | Topical skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |